Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.60 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | GLP1R | P43220 | 10/20 | 0.57 |
| ▸ | SCTR | P47872 | 1/20 | 0.57 |
| ▸ | CCKBR | P32239 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29880436 | 0.97 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL29726691 | 0.97 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL30778184 | 0.97 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL29994110 | 0.95 | CALCR (0.58) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL29682931 | 0.92 | GLP1R (0.65) | CALCRGLP1RSCTRCCKBR | |
| SCHEMBL31139948 | 0.92 | GLP1R (0.66) | GLP1RSCTRCCKBR | |
| SCHEMBL30427404 | 0.92 | CRHR1 (0.66) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL31243560 | 0.92 | CALCR (0.59) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL30387584 | 0.91 | GLP1R (0.65) | CALCRGLP1RSCTRCCKBR | |
| SCHEMBL29378700 | 0.91 | CALCR (0.54) | CALCRCRHR1CRHR2GLP1RSCTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119876131-A | GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof | IONIS制药公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-111448207-B | GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof | IONIS制药公司 | 2024-11-01 | — | — | CN | disclosed |